Computer-assisted evaluation of antibiotic regimen coverage and cost

Clinical Therapeutics

Volumn 21, Issue 8, 1999, Pages 1418-1425

  Day, David ^a   Lubowski, Teresa J ^a   Yamaga, Cynthia C ^a   Main, John ^a   Van Vleet, John ^a   Ambegaonkar, Ambarish ^a  

^a PFIZER INC   (United States)

Author keywords

Antibiotics; Assessment; Cost effectiveness; Infectious disease treatment

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; COMPUTER PROGRAM; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; HOSPITAL PHARMACY; HUMAN; INFECTION;

EID: 0032821882     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(99)80042-3     Document Type: Article

References (14)

1. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann Intern Med. 1996;124: 884-890.
2. Rifenburg RP, Paladino JA, Hanson SC, et al. Benchmark analysis of strategies hospitals use to control antimicrobial expenditures. Am J Health-Syst Pharm. 1996;53:2054-2062.
3. Levy SB. Multidrug resistance-a sign of the times. N Engl J Med. 1998;338:1376-1378.
4. Craig WA. The future-can we learn from the past? Diagn Microbiol Infect Dis. 1997;27:49-53.
5. Nicolle LE, Bentley D, Garibaldi R, et al. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol. 1996;17:119-128.
6. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993; 148:1418-1426.
7. Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995:53.
8. Mandell GL, Douglas RG, Bennett JE, et al, eds. Principles and Practice of Infectious Diseases: Antimicrobial Therapy 1996/1997. New York: Churchill Livingstone; 1996:46-64.
9. American Thoracic Society. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med. 1995;153: 1711-1725.
10. Bohnen JMA, Solomkin JS, Dellinger EP, et al. Guidelines for clinical care: Anti-infective agents for intra-abdominal infection. Arch Surg. 1992;127:83-89.
11. Lorian V, Burns L. Predictive value of susceptibility tests for the outcome of antibacterial therapy. J Antimicrob Chemother. 1990;25:175-181.
12. Schentag JJ, Nix DE, Forrest A, Adelman MH. AUIC-the universal parameter within the constraint of a reasonable dosing interval. Ann Pharmacother. 1996;30: 1029-1031.
13. Dalla Costa T, Derendoff H. AUIC-a general target for the optimization of dosing regimens of antibiotics? Ann Pharmacother. 1996;30:1024-1028.
14. Schentag JJ, Nix DE, Adelman MH. Mathematical examination of dual individualization principles (1): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin. DICP. 1991; 25:1050-1057.